US Stock MarketDetailed Quotes

Larimar Therapeutics (LRMR)

Watchlist
  • 5.090
  • +0.050+0.99%
Close Apr 8 16:00 ET
  • 5.090
  • 0.0000.00%
Post 17:38 ET
528.76MMarket Cap-2.24P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Larimar Therapeutics (LRMR) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
89.79%172.5M
104.58%64.02M
171.02%49.5M
12.98%27.79M
86.38%31.19M
117.66%90.89M
120.96%31.29M
76.65%18.26M
155.71%24.6M
119.12%16.73M
Selling and administrative expenses
3.75%18.27M
1.98%4.65M
5.13%4.57M
-10.03%4.42M
22.16%4.64M
25.01%17.61M
29.62%4.56M
15.74%4.35M
31.30%4.92M
23.41%3.8M
-General and administrative expense
3.75%18.27M
1.98%4.65M
5.13%4.57M
-10.03%4.42M
22.16%4.64M
25.01%17.61M
29.62%4.56M
15.74%4.35M
31.30%4.92M
23.41%3.8M
Research and development costs
110.46%154.22M
122.05%59.37M
222.80%44.93M
18.73%23.37M
105.21%26.55M
164.83%73.28M
151.11%26.74M
111.37%13.92M
235.01%19.68M
183.63%12.94M
Operating profit
-89.79%-172.5M
-104.58%-64.02M
-171.02%-49.5M
-12.98%-27.79M
-86.38%-31.19M
-117.66%-90.89M
-120.96%-31.29M
-76.65%-18.26M
-155.71%-24.6M
-119.12%-16.73M
Net non-operating interest income expense
Other net income (expense)
-33.66%6.82M
-38.44%1.52M
-35.37%1.79M
-45.83%1.61M
-8.32%1.91M
113.89%10.29M
111.21%2.47M
116.86%2.77M
137.00%2.97M
87.22%2.08M
Other non- operating income (expenses)
-33.66%6.82M
-38.44%1.52M
-35.37%1.79M
-45.83%1.61M
-8.32%1.91M
113.89%10.29M
111.21%2.47M
116.86%2.77M
137.00%2.97M
87.22%2.08M
Income before tax
-105.54%-165.67M
-116.83%-62.5M
-207.84%-47.71M
-21.06%-26.18M
-99.82%-29.28M
-118.15%-80.6M
-121.84%-28.82M
-71.00%-15.5M
-158.51%-21.63M
-124.55%-14.65M
Income tax
Net income
-105.54%-165.67M
-116.83%-62.5M
-207.84%-47.71M
-21.06%-26.18M
-99.82%-29.28M
-118.15%-80.6M
-121.84%-28.82M
-71.00%-15.5M
-158.51%-21.63M
-124.55%-14.65M
Net income continuous Operations
-105.54%-165.67M
-116.83%-62.5M
-207.84%-47.71M
-21.06%-26.18M
-99.82%-29.28M
-118.15%-80.6M
-121.84%-28.82M
-71.00%-15.5M
-158.51%-21.63M
-124.55%-14.65M
Minority interest income
Net income attributable to the parent company
-105.54%-165.67M
-116.83%-62.5M
-207.84%-47.71M
-21.06%-26.18M
-99.82%-29.28M
-118.15%-80.6M
-121.84%-28.82M
-71.00%-15.5M
-158.51%-21.63M
-124.55%-14.65M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-105.54%-165.67M
-116.83%-62.5M
-207.84%-47.71M
-21.06%-26.18M
-99.82%-29.28M
-118.15%-80.6M
-121.84%-28.82M
-71.00%-15.5M
-158.51%-21.63M
-124.55%-14.65M
Basic earnings per share
-71.97%-2.27
-62.22%-0.73
-154.17%-0.61
-20.59%-0.41
-70.37%-0.46
-57.14%-1.32
-55.17%-0.45
-14.29%-0.24
-78.95%-0.34
-80.00%-0.27
Diluted earnings per share
-71.97%-2.27
-62.22%-0.73
-154.17%-0.61
-20.59%-0.41
-70.37%-0.46
-57.14%-1.32
-55.17%-0.45
-14.29%-0.24
-78.95%-0.34
-80.00%-0.27
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 89.79%172.5M104.58%64.02M171.02%49.5M12.98%27.79M86.38%31.19M117.66%90.89M120.96%31.29M76.65%18.26M155.71%24.6M119.12%16.73M
Selling and administrative expenses 3.75%18.27M1.98%4.65M5.13%4.57M-10.03%4.42M22.16%4.64M25.01%17.61M29.62%4.56M15.74%4.35M31.30%4.92M23.41%3.8M
-General and administrative expense 3.75%18.27M1.98%4.65M5.13%4.57M-10.03%4.42M22.16%4.64M25.01%17.61M29.62%4.56M15.74%4.35M31.30%4.92M23.41%3.8M
Research and development costs 110.46%154.22M122.05%59.37M222.80%44.93M18.73%23.37M105.21%26.55M164.83%73.28M151.11%26.74M111.37%13.92M235.01%19.68M183.63%12.94M
Operating profit -89.79%-172.5M-104.58%-64.02M-171.02%-49.5M-12.98%-27.79M-86.38%-31.19M-117.66%-90.89M-120.96%-31.29M-76.65%-18.26M-155.71%-24.6M-119.12%-16.73M
Net non-operating interest income expense
Other net income (expense) -33.66%6.82M-38.44%1.52M-35.37%1.79M-45.83%1.61M-8.32%1.91M113.89%10.29M111.21%2.47M116.86%2.77M137.00%2.97M87.22%2.08M
Other non- operating income (expenses) -33.66%6.82M-38.44%1.52M-35.37%1.79M-45.83%1.61M-8.32%1.91M113.89%10.29M111.21%2.47M116.86%2.77M137.00%2.97M87.22%2.08M
Income before tax -105.54%-165.67M-116.83%-62.5M-207.84%-47.71M-21.06%-26.18M-99.82%-29.28M-118.15%-80.6M-121.84%-28.82M-71.00%-15.5M-158.51%-21.63M-124.55%-14.65M
Income tax
Net income -105.54%-165.67M-116.83%-62.5M-207.84%-47.71M-21.06%-26.18M-99.82%-29.28M-118.15%-80.6M-121.84%-28.82M-71.00%-15.5M-158.51%-21.63M-124.55%-14.65M
Net income continuous Operations -105.54%-165.67M-116.83%-62.5M-207.84%-47.71M-21.06%-26.18M-99.82%-29.28M-118.15%-80.6M-121.84%-28.82M-71.00%-15.5M-158.51%-21.63M-124.55%-14.65M
Minority interest income
Net income attributable to the parent company -105.54%-165.67M-116.83%-62.5M-207.84%-47.71M-21.06%-26.18M-99.82%-29.28M-118.15%-80.6M-121.84%-28.82M-71.00%-15.5M-158.51%-21.63M-124.55%-14.65M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -105.54%-165.67M-116.83%-62.5M-207.84%-47.71M-21.06%-26.18M-99.82%-29.28M-118.15%-80.6M-121.84%-28.82M-71.00%-15.5M-158.51%-21.63M-124.55%-14.65M
Basic earnings per share -71.97%-2.27-62.22%-0.73-154.17%-0.61-20.59%-0.41-70.37%-0.46-57.14%-1.32-55.17%-0.45-14.29%-0.24-78.95%-0.34-80.00%-0.27
Diluted earnings per share -71.97%-2.27-62.22%-0.73-154.17%-0.61-20.59%-0.41-70.37%-0.46-57.14%-1.32-55.17%-0.45-14.29%-0.24-78.95%-0.34-80.00%-0.27
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.68%
Sample Name
Sample Code
 +16.26%
Sample Name
Sample Code
 +13.08%
4
United Sts Brent Oil Fd Lp Unit
BNO
+10.72%
5
ProShares Ultra Energy
DIG
+9.35%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +14.90%
Sample Name
Sample Code
 +14.44%
Sample Name
Sample Code
 +13.72%
4
ASE Technology
ASX
+11.35%
5
Kingsoft Cloud
KC
+9.51%
View More
Middle East conflict spreads to the stock market! How should investors respond?
The US-Iran situation has reached a major turning point as Trump announced a two-week suspension of military actions against Iran, with both Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -